# Eurofins Lancaster Laboratories, Inc - Inspection Records

Source: https://www.globalkeysolutions.net/companies/eurofins-lancaster-laboratories-inc/fdb282e8-01fc-4626-8794-1b7394ba0890

> Inspection records and compliance data for Eurofins Lancaster Laboratories, Inc in Lancaster, Pennsylvania. Access full analysis and detailed observations.

---

## Details

- Name: Eurofins Lancaster Laboratories, Inc
- FEI Number: 2513291
- City: Lancaster
- State: Pennsylvania
- Country Name: United States
- Address Line 1: 2425 New Holland Pike
- Zip Code: 17601
- Business Operations: API/FDF ANALYTICAL TESTING

## Related Documents

- [FDA Inspection 1284580 - Eurofins Lancaster Laboratories, Inc - 2025-09-23](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-lancaster-laboratories-inc/d905bc5d-0d6c-4d5e-b731-266193c1d3d1) — source: FDA, date: September 23, 2025
- [FDA Inspection 1284580 - Eurofins Lancaster Laboratories, Inc - 2025-09-23](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-lancaster-laboratories-inc/35146b05-5a24-4e26-8820-288e62f4209b) — classification: No Action Indicated (NAI), source: FDA, date: September 23, 2025
- [483 - Eurofins Lancaster Laboratories, Inc - 2025-08-26](https://www.globalkeysolutions.net/records/483/eurofins-lancaster-laboratories-inc/446b35d2-f9c4-42f5-9658-5d423765db1f) — source: FDA, date: August 26, 2025
- [FDA Inspection 1279557 - Eurofins Lancaster Laboratories, Inc - 2025-08-26](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-lancaster-laboratories-inc/204a3e19-1058-4e10-b09a-d0d509c4df22) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 26, 2025
- [EIR - Eurofins Lancaster Laboratories, Inc - 2021-10-21](https://www.globalkeysolutions.net/records/eir/eurofins-lancaster-laboratories-inc/54ec3aa7-0ea2-469c-81e8-be7f1a979149) — source: FDA, date: October 21, 2021
- [FDA Inspection 1156933 - Eurofins Lancaster Laboratories, Inc - 2021-10-21](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-lancaster-laboratories-inc/f3ad05fc-9ab4-40d0-b37f-c5f61e8ee8d5) — classification: No Action Indicated (NAI), source: FDA, date: October 21, 2021
- [FDA Inspection 1156933 - Eurofins Lancaster Laboratories, Inc - 2021-10-21](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-lancaster-laboratories-inc/4d87f249-7742-43a1-954b-3158e3a5047a) — classification: No Action Indicated (NAI), source: FDA, date: October 21, 2021
- [FDA Inspection 1156933 - Eurofins Lancaster Laboratories, Inc - 2021-10-21](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-lancaster-laboratories-inc/6d9dc317-2a02-43dc-bcba-6ff0360cc209) — classification: No Action Indicated (NAI), source: FDA, date: October 21, 2021
- [FDA Inspection 1113269 - Eurofins Lancaster Laboratories, Inc - 2019-10-17](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-lancaster-laboratories-inc/0477d2bf-7889-495f-9b67-a075a013c867) — classification: No Action Indicated (NAI), source: FDA, date: October 17, 2019
- [FDA Inspection 1113269 - Eurofins Lancaster Laboratories, Inc - 2019-10-17](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-lancaster-laboratories-inc/5c27ca64-d1ab-4e70-84d3-1cd41dd1b051) — classification: No Action Indicated (NAI), source: FDA, date: October 17, 2019
- [EIR - Eurofins Lancaster Laboratories, Inc - 2019-09-13](https://www.globalkeysolutions.net/records/eir/eurofins-lancaster-laboratories-inc/a3b9943b-3208-47cb-9588-8279e30fd8e6) — source: FDA, date: September 13, 2019
- [FDA Inspection 1106449 - Eurofins Lancaster Laboratories, Inc - 2019-09-13](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-lancaster-laboratories-inc/51a1f2e6-5e75-4452-b409-285f118967eb) — classification: No Action Indicated (NAI), source: FDA, date: September 13, 2019
- [FDA Inspection 1029560 - Eurofins Lancaster Laboratories, Inc - 2017-09-28](https://www.globalkeysolutions.net/records/fda_inspections/eurofins-lancaster-laboratories-inc/5f4ad951-3983-4065-a6a1-3056bae2a886) — classification: No Action Indicated (NAI), source: FDA, date: September 28, 2017

## Related Companies

- [WuXi AppTec Inc.](https://www.globalkeysolutions.net/companies/wuxi-apptec-inc/9d289339-3edc-4d2e-aacb-4d849335e75d)
- [Intertek USA Inc.](https://www.globalkeysolutions.net/companies/intertek-usa-inc/2c61102d-28cb-4e8b-b5c0-01d3148f07d0)
- [Sterigenics Germany GmbH](https://www.globalkeysolutions.net/companies/sterigenics-germany-gmbh/f2e9492c-1068-4565-9325-7d580f6419d4)
- [Sumika Chemical Analysis Service, Ltd.](https://www.globalkeysolutions.net/companies/sumika-chemical-analysis-service-ltd/075ab6c9-b05d-47d0-8d9a-0aa4807153a6)
- [New Jersey Laboratories](https://www.globalkeysolutions.net/companies/new-jersey-laboratories/d310e635-49c8-4881-97d4-757fe831e691)
- [RiconPharma LLC](https://www.globalkeysolutions.net/companies/riconpharma-llc/419021d0-2e97-46b7-977f-1df932afc40b)
- [Tolmar, Inc.](https://www.globalkeysolutions.net/companies/tolmar-inc/0f03b95a-a7e1-4a49-a5f7-5f6842df7d92)
- [Paradox Inc](https://www.globalkeysolutions.net/companies/paradox-inc/14c91a8f-7d1f-4de2-a85f-7e7a04034113)
- [Boston Analytical, Inc.](https://www.globalkeysolutions.net/companies/boston-analytical-inc/a21fce05-8b60-4a91-ac00-217015ac046a)
- [Advanced Testing Laboratory, Inc.](https://www.globalkeysolutions.net/companies/advanced-testing-laboratory-inc/ffcab2ff-2b21-404d-a50a-7f2e049215ac)

## Related Officers

- [Bradley E. Benasutti](https://www.globalkeysolutions.net/people/bradley-e-benasutti/7a03a364-ad6f-4a80-8504-3fbddc50af58)
- [company_representative](https://www.globalkeysolutions.net/people/gary-siko/7ba44bcb-e182-45e2-ac39-df231b7bf315)
- [other](https://www.globalkeysolutions.net/people/earl-hess/0e7a0fc1-a6b2-4962-b33a-8182956834c6)
- [company_representative](https://www.globalkeysolutions.net/people/koreene-n-d-agostino/66d56d62-e4f5-41f1-b423-0b12301d5c06)
- [Investigator](https://www.globalkeysolutions.net/people/junho-pak/4abe53fb-ad20-490d-9e71-6216a9f863f5)